School of Medicine
Showing 1-100 of 131 Results
-
Florian Bach
Postdoctoral Scholar, Infectious Diseases
BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda.
-
Adrian Matias Bacong
Postdoctoral Scholar, Cardiovascular Medicine
Current Research and Scholarly InterestsAdrian M. Bacong, PhD, MPH is a social epidemiologist by training. His research seeks to identify social and structural factors that underlie health inequities by race, ethnicity, and immigration status. Specifically, his work has explored the role of socioeconomic factors in explaining health disparities by immigrant legal status and visa type. Furthermore, Adrian is interested in the effects of immigration on health. He received a NIH F31 award (1F31MD015931-01A1) to examine factors affecting the health of Filipino migrants to the U.S. compared to Filipinos remaining in the Philippines.
Adrian has also examined the intersections of race, ethnicity, and immigration status among older adults. Finally, Adrian written upon the role of data disaggregation as a method of public health critical race praxis. Currently, Adrian is researching the role of social and policy level factors underlying health disparities among immigrants. -
Cameron Scott Bader
Postdoctoral Scholar, Bone Marrow Transplantation
BioMy research is focused on using preclinical models to develop novel therapies which improve outcomes for patients receiving allogeneic hematopoietic stem cell transplantation. Currently, my work aims to establish strategies to reduce the risk of relapse after allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease or interfering with donor stem cell engraftment.
-
Adi badhwar
Masters Student in Clinical Informatics Management, admitted Summer 2022
BioBuilding healthcare technology products powered by deep-learning & big data from concept to scale
-
Nitish Badhwar
Clinical Professor, Medicine - Cardiovascular Medicine
BioNitish Badhwar, MD is Professor of Medicine and Director of Cardiac Electrophysiology Training Program at Stanford University School of Medicine. Dr. Badhwar received his medical degree from Maulana Azad Medical College (University of Delhi, India). After completing his internal medicine training from New York Hospital of Queens (affiliated with Cornell Medical School), he worked as faculty in the Department of Medicine at Hospital of St. Raphael (Yale University School of Medicine). He completed Cardiac Electrophysiology training at UCSF with Dr. Scheinman. After being on faculty at UCSF for 15 years he recently joined the Arrhythmia Service at Stanford Hospital. He is a Fellow of American College of Cardiology and Heart Rhythm Society. He has been named best doctor in cardiac electrophysiology in San Francisco Magazine since 2015 (2015-2025). This is nominated by his peers. He was given Excellence in Teaching award in Medical Education by Academy of Medical Educators in 2015 and ACC Distinguished Teacher Award in 2024. He was an invited speaker at prestigious international meetings including Oriental Congress of Cardiology (OCC) in Shanghai, China; Cardiostim EHRA /Europace in Nice, France; Asia Pacific Heart Rhythm Society (APHRS) in Seoul, S Korea; American Heart Association Annual Scientific Session in New Orleans, LA and Indian Heart Rhythm Society in New Delhi, India.
Clinical Interest: Dr. Badhwar's clinical interest is in complex catheter ablation procedures including mapping and ventricular tachycardia (VT), atrial fibrillation (AF) and supraventricular tachycardia (SVT) including junctional variants of SVT. He started the epicardial ablation program at UCSF and also worked with Dr. Randall Lee to perform the first percutaneous epicardial left atrial appendage (LAA) ligation in the Bay Area in patients with atrial fibrillation. He has also differentiated himself in the field of electrophysiology by performing hybrid procedures with CT surgeons in patients with AF and VT. He is also involved in device implantation including pacemakers, ICD and biventricular pacing for heart failure.
Research Interest: Dr. Badhwar has published electrophysiologic characteristics of SVTs including atrial tachycardia arising from the coronary sinus musculature, para-hisian atrial tachycardia, left sided AVNRT, junctional tachycardia and nodofascicular tachycardia. He has also published on the use of nuclear medicine (ERNA) in assessing left ventricular dyssynchrony as well as optimal pacing sties in patients with heart failure requiring biventricular pacing. He has described the unique clinical characteristics of epicardial idiopathic VT arising from the cardiac crux and septal fascicular VT. He has also published clinical outcomes of combining LAA ligation with catheter ablation of atrial fibrillation (first in human percutaneous closed chested Maze procedure) and participated in multi-center randomized trials of hybrid AF ablation ( DEEP trial and aMAZE trial). He was part of the VINTAGE project that used novel technique for ablation of intramural deep septal VT. -
Jehan Bahrainwala, MD, FASN
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Bahrainwala is a board-certified, fellowship-trained nephrologist with the Stanford Medicine Kidney Clinic at Boswell. She is a Certified Hypertension Specialist practicing at the AHA-Certified Stanford Hypertension Center. One of her main clinical areas of focus is the diagnosis and treatment of resistant hypertension and secondary hypertension. She also has a clinical interest in caring for patients who are pregnant or planning pregnancy with hypertension and kidney disease. In addition to hypertension, she also cares for patients with all types of kidney diseases. Her extensive experience includes caring for patients with electrolyte abnormalities, kidney stones, chronic kidney disease and end stage kidney disease.
Dr. Bahrainwala is skilled at creating connections with her patients. She treats the whole person rather than the condition. She also strongly believes in patient education and involving them in the medical decision-making process. She integrates their goals of care and other aspects of advanced care planning into treatment planning. She is also interested in the conservative care of elderly patients with advanced kidney disease. She has formal communication skills training in discussing serious illnesses with patients through Vital Talk.
In addition to being a clinician, she is committed to and involved in the medical education of trainees at all levels including medical students, residents and fellows. She is a fellow and a member of the American Society of Nephrology. Additionally, she is a member of the National Kidney Foundation and the American Heart Association. She is double board certified in internal medicine and nephrology. -
Xiangqi Bai
Postdoctoral Scholar, Oncology
BioMy research is focused on computational and systems biology. My primary research interest lies in developing new computational algorithms and statistical methods for the analysis of complex data in biological systems, especially related to the large-scale single-cell RNA sequencing data. The specific topics I have examined include:
1. Integration of single-cell multi-omics datasets for tumor
2. Statistical test of cell developmental trajectories
3. Visualization and reconstruction of single-cell RNA sequencing data
4. Computational analysis of the bifurcating event revealed by dynamical network biomarker methods -
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Matthew C. Baker, MD MS
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Baker is the Associate Division Chief in the Division of Immunology and Rheumatology at Stanford University and an internationally recognized expert in IgG4-related disease, as well as the Co-Founder and Co-Director of the Stanford Multidisciplinary Sarcoidosis Program. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker's clinical research program is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials in IgG4-related disease, sarcoidosis, Sjogren's disease, and rheumatoid arthritis. His epidemiological work aims to better understand disease mechanisms and identify novel drug targets, with a particular interest in repurposing existing drugs for the treatment of osteoarthritis.
-
Niaz Banaei
Professor of Pathology and of Medicine (Infectious Diseases)
Current Research and Scholarly InterestsHis research interests include (1) development, assessment, and improvement of novel infectious diseases diagnostics, (2) enhancing the quality of C. difficile diagnostic results, and (3) characterization of M. tuberculosis virulence determinants.
-
Bhabna Banerjee
Casual Employee, Medicine - Primary Care and Population Health
BioBhabna Banerjee is an illustrator and data journalist based in Vancouver, Canada. She graduated from York University with a BFA in Media Production and Visual Journalism and was named The Global Leader of Tomorrow Scholar from the class of 2020. Her interests include environmental policy, biodiversity loss, climate migration, and extreme weather. She has previously covered climate and environmental issues for publications such as Forbes, World Economic Forum, El Tecolote, Courrier International, and the Knight Foundation. In 2022, she founded Planet Anomaly to improve climate literacy and make environmental news more accessible through illustrated data visualizations. Since then, she has helped environmental organizations communicate their data and research and has collaborated with the Rocky Mountain Institute, Climate Central, Datawrapper, and Down to Earth. At Stanford, she will continue to develop innovative ways of visual storytelling that make climate reporting more comprehensible.
-
Subhas Banerjee
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Banerjee is the Director of Endoscopy at the Stanford University Medical Center. His research interests include evaluation of advanced endoscopic procedures (ERCP, choledochoscopy and endoscopic ultrasound) in the diagnosis and management of benign and malignant pancreatic and biliary disease. Additional interests include the development of new endoscopic devices and instruments.
-
Narges Baniasadi
Academic Staff - Hourly - CSL, Medicine - Stanford Prevention Research Center
BioDr. Narges Baniasadi is founder and executive director of Emergence program at Stanford. She develops educational and translational programs for improving societal health through entrepreneurship. She is also Adjunct Professor with the Department of Medicine where she teaches impact entrepreneurship in the areas related to Prevention and Health Equity. Narges has led multiple initiatives and businesses in the intersection of Technology and Life Sciences for more than a decade. She founded Bina, a pioneering Bioinformatics company, out of a decade of research at Stanford and UC Berkeley. Bina developed high performance computing platforms and AI solutions for cancer research and genomics analysis. Later, upon acquisition of Bina by Roche, she led the clinical software development and AI research as VP of Informatics at Roche Sequencing until 2018.
-
Grant Barber
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Grant Barber is a Clinical Assistant Professor at Stanford University. His clinical passion is in the care of patients suffering from inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. After completing his medical training at Harvard Medical School, he completed his training in gastroenterology as well as a Master's degree in clinical research at Stanford. He completed additional training in advanced IBD management at Stanford before joining faculty. His research is focused on male reproductive health in IBD, quality improvement in the provision of IBD care, and economic studies to identify strategies that provide excellent outcomes while being sustainable within the healthcare system. He is an expert in tailoring evidence-based therapies to need of individual people with IBD.
-
Michele Barry, MD, FACP
Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine, Senior Fellow at the Woods Institute and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsAreas of research
Ethical Aspects of research conducted overseas
Clinical Tropical Diseases
Globalization's Impact upon Health Disparities
Human and Planetary Heath
Women Leadership -
Umang Barvalia
Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
BioUmang Barvalia earned his M.B,B.S degree from Medical College, Baroda in Vadodara, India. He completed his internal medicine residency at Marshfield Clinic- St. Joseph’s Hospital, Marshfield, WI where he also served as a chief resident. He was a chief fellow during his Pulmonary and Critical Care Medicine fellowship at University of Wisconsin, Madison, WI. He is currently working as a Board Certified Internal Medicine, Pulmonary and Critical Care Medicine Physician at the Santa Clara Valley Medical Center (SCVMC), San Jose. – a county hospital that serves as a teaching site for Stanford residents and fellows. He holds an appointment of Clinical Associate Professor (affiliated) at Stanford University School of Medicine due to his involvement in training of pulmonary and critical medicine fellows.
His professional interests include point-of-care ultrasound (POCUS) and medical education. He is certified in Critical Care Echocardiography by the National Board of Echocardiography (NBE) and teaches residents and fellows POCUS in the ICU and on the pulmonary consult service.
As a lung specialist, he cares for patients with chronic lung conditions like asthma, pulmonary hypertension, COPD, Interstitial lung disease, diseases involving the pleura and lung cancer. He also established the Endobronchial Ultrasound Program at SCMVC that helps in the diagnosis and care of lung cancer patients.
As a full time faculty in the intensive care unit, he treats patients with a variety of conditions including sepsis, liver failure, respiratory failure, post cardiac arrest and stroke. Along with his peers, he introduced prone position ventilation at SCVMC that helps in management of patients with ARDS. -
Preetha Basaviah, M.D.
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMedical education, preparation for clerkship curricula and hospital medicine.
-
Marina Basina
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly InterestsDiabetes type I and type II, insulin pump therapy, glucose sensor technology, insulin resistance, PCOS, thyroid disorders
-
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner is an Assistant Professor in the Department of Internal Medicine, Division of Cardiovascular Medicine and Electrophysiology. Following internal medicine residency, cardiovascular medicine and advanced heart failure fellowship trainings at University of California, San Diego and electrophysiology fellowship at Stanford University, Dr. Baykaner joined Stanford University faculty in 2018. She has published over 200 papers, book chapters and abstracts including over 100 original peer-reviewed articles, and delivered over 100 invited presentations in national and international meetings. She serves as associate editor, section editor and editorial board member of four electrophysiology journals and served in guideline writing committees.
Dr. Baykaner’s current research interests include outcomes research, epidemiology and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient related outcomes regarding atrial fibrillation (AF) ablation. She received prior research funding from American Heart Association and Heart Rhythm Society. Dr. Baykaner's clinical practice focuses on ablation of atrial and ventricular arrhythmias, SVTs, inappropriate sinus tachycardia management, device implantation and device extraction.
Dr. Baykaner is an active member of American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS) and European Society of Cardiology (ESC). She serves as an elected member of the Digital Health Committee for HRS, and previously served as an elected member of the HRS Communications Committee and ACC Task Force ICD research committee. -
Laren Becker
Assistant Professor of Medicine (Gastroenterology)
BioI am a physician-scientist in the Division of Gastroenterology at Stanford University. My clinical and research interest has been in neurogastroenterology. Specifically, my research has been exploring the interplay between immune cells and the enteric nervous system, and evaluating how perturbations of this interaction as a result of aging disrupts gastrointestinal neuromuscular function. Ultimately, my hope is that insights from this research provide novel therapies for treating patients with motility disorders like constipation and irritable bowel syndrome.
-
Malte Becker
Affiliate, Medicine - Primary Care and Population Health
BioMalte Becker is a postdoctoral researcher at the Heidelberg Institute of Global Health and Stanford University.
He obtained his PhD in development economics from the Kiel Institute for the World Economy and the University of Göttingen.
His research focuses on global health, development economics, and health economics.
Personal website: https://sites.google.com/view/maltebecker/home
Contact: maltebe@stanford.edu -
Harmeet Bedi
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Harmeet Bedi is the Director of Interventional Pulmonology & Bronchoscopy at Stanford University. His expertise is in minimally invasive techniques used in the diagnosis and treatment of various airway and lung diseases such as lung cancer, benign & malignant airway obstruction, and pleural diseases. He specializes in rigid & flexible bronchoscopy, robotic bronchoscopy, airway stent placement, balloon bronchoplasty, endobronchial ultrasound (EBUS), and various pleural procedures. He also specializes in a variety of tumor ablative therapies including laser therapy, electrocautery, argon plasma coagulation (APC), brachytherapy, and cryotherapy.
He founded the cone-beam computed tomography (CBCT) - guided bronchoscopy program at Stanford in 2019. CBCT-guided bronchoscopy is a novel and cutting-edge technique which combines bronchoscopy with CT imaging, allowing for improved localization and diagnosis of peripheral lung nodules. Additionally, CBCT-guided bronchoscopy will allow for numerous potential cancer therapies that are currently under development.
Dr. Bedi is a principal investigator and co-investigator on multiple clinical trials related to bronchoscopy, thoracic imaging, pulmonary nodules, and lung cancer. Specifically, he has multiple research interests within the realm of bronchoscopic device innovation and CBCT-guided bronchoscopy. -
Eran Bendavid
Professor of Medicine (Primary Care and Population Health), of Health Policy, Senior Fellow at the Woods Institute for the Environment and, by courtesy, at the Freeman Spogli Institute for International Studies
Current Research and Scholarly InterestsEffect of global health policies on health of individuals in developing countries, global health, HIV and TB.
-
Roberto J. Bernardo MD, MS, ATSF
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsExercise hemodynamics and cardiopulmonary exercise testing
-
Allison Betof, MD, PhD
Associate Professor of Medicine (Oncology)
BioDr. Allison Betof is an Associate Professor of Medicine (Oncology), Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and Mark & Mary Stevens Endowed Scholar in Melanoma at Stanford University School of Medicine. Dr. Betof completed her MD and PhD at Duke University, Internal Medicine residency at Massachusetts General Hospital (Harvard University) and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Betof’s laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is internationally recognized for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for the treatment of melanoma and other solid tumors. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), Melanoma Research Alliance, and Melanoma Research Foundation.
-
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Sushma Bharadwaj, MD
Clinical Assistant Professor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology. -
Ami Bhatt
Professor of Medicine (Hematology) and of Genetics
On Partial Leave from 09/29/2025 To 12/16/2025Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
-
Hilarey Ransom Bhatt
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Bhatt is an expert clinician, educator, and health system leader in the specialty of internal medicine. She earned her MD from University of California San Francisco School of Medicine and completed her training at UCSF’s Internal Medicine residency program. Dr. Bhatt is certified by the American Board of Internal Medicine. Dr. Bhatt cares for people ages 18 and up. She practices at Stanford Express Care in Palo Alto and San Jose, where she serves as the Medical Director of the clinic. She has a particular interest in the care of medically complex patients and in teaching and practicing evidence-based medicine. She believes that the patient-clinician relationship is the foundation of good care and strives to develop respectful and collaborative relationships with all her patients.
-
Brian Blackburn
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsMy interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya
-
Alexandria Blacker
Program Director - Community Partnership, Medicine
BioAlexandria Blacker, PhD, MPH is the Director of the Stanford Department of Medicine’s Community Partnership Program and adjunct fauclty in the Milken School of Public Health at George Washington University. As a public health professional, Dr. Blacker has worked in breast cancer behavioral research, primary care redesign, community health, health care worker well-being, and program implementation.
In her current role, she focuses on building bi-directional, equitable, and sustainable partnerships to advance local health equity. Dr. Blacker’s research focuses on understanding processes to developing sustainable community-academic partnerships and exploring the complexity of interprofessional health care teams including teaming behaviors and contextual influences.
Dr. Blacker has had the pleasure of working with Stanford in both the health care and University settings. As a Stanford Health Care employee, Dr. Blacker worked for the Stanford Coordinated Care clinic and managed the disease management program for employees and staff. She also worked closely with her colleagues to assist in the change management efforts for the Primary Care 2.0 redesign implementation by developing educational curriculum and go-live execution with physicians, clinic managers, and team members.
As a University employee, Dr. Blacker previously worked as part of the HealthySteps to Wellness team as the Wellness Manager for Stanford Health Care. In this role, she worked cross-functionally with department heads to design and manage wellness-based trainings. She has developed curricula in positive psychology, stress management, and behavior change. She has conducted over 100 trainings and conducted programmatic evaluations to streamlining processes to increase overall effectiveness. -
Terrence Blaschke
Professor of Medicine and of Molecular Pharmacology, Emeritus
Current Research and Scholarly InterestsClinical pharmacology of antiretroviral drugs
Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.
Drug development -
Douglas W. Blayney
Professor of Medicine (Oncology), Emeritus
Current Research and Scholarly InterestsImproving the quality of cancer care at Stanford, in our network of care, and nationally
-
Catherine Blish
George E. and Lucy Becker Professor in Medicine
Current Research and Scholarly InterestsThe major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.
-
Gordon Bloom
Lecturer, Medicine - Primary Care and Population Health
BioGordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford, Harvard and Princeton. He teaches about the design, development and leadership of innovative social impact ventures in global health and environmental sustainability.
At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, and an advisor in the Distinguished Careers Institute (DCI), and the Knight-Hennessy Scholars Program, and cofounder of the Stanford Sustainable Societies Lab.
At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President’s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.
At Princeton, Gordon served as Dean’s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the [Woodrow Wilson] School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.
At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology–influenced, interdisciplinary incubator for social impact ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies Program faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford’s Freeman Spogli Institute for International Studies.
Many of the talented students and fellows in Gordon’s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.
Gordon is a co-author in the edited volume Frontiers in Social Innovation (N. Malhotra, ed., Harvard Business Review Press, 2022) and Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company (EDAP Technomed, USA) and in international strategy consulting (Bain & Co. Ltd.).
Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey and son Jason, and live in the Frenchman's Hill residential section of campus. -
Christina Bodurow
Affiliate, Medicine - Med/Gastroenterology and Hepatology
BioChris has a proven record of accomplishment delivering results to pharmaceutical and scientific organizations, including 33 years of management experience at Eli Lilly and Company, within Lilly Research Laboratories (LRL), 3.5 years in a global leadership role at IQVIA, and now as Deputy Director and COO of a significant NIH/NIAID research grant at Stanford University Medical School.
Over the years, Chris has served as a leader of multiple global teams in drug development and R&D Operations, representing her organizations in multiple external settings, including scientific, academic, drug development and R&D Operations forums.
In, December 2017, Chris retired from Lilly as Sr. Director, External Sourcing, leading an enterprise-wide R&D operations group that partnered with LRL functions to assess, on-board, and govern third party organizations across the entire drug development value chain, from pre-clinical, through clinical, regulatory, safety, health outcomes, product and device development, and diagnostics. The division consolidated both corporate and external requirements to deliver high-quality, risk-based, third party governance, oversight and alliance management for the LRL Development organization.
In February 2019, Chris joined IQVIA as the Vice-President of Strategy & Operations for DSSR, and subsequently moved in the role of Vice-President, Global Regulatory Affairs.
Specialties: Pharmaceutical Development, R&D Operations, Molecule Submission/Approval/Launch, Product Lifecycle Planning and Development, R&D Business Systems design and delivery. Third Party Management, Women's Leadership Development. -
Bryan Bohman
Clinical Professor, Medicine - Primary Care and Population Health
BioBryan Bohman is Associate Chief Medical Officer for Workforce Health and Wellness. Additional roles include Clinical Professor of Medicine and of Anesthesiology, Co-Director of the Clinical Effectiveness Leadership Training (CELT) program and Senior Advisor to the WellMD Center.
Bryan trained at Stanford in internal medicine and anesthesiology. After two decades of clinical practice in community-based anesthesiology, he served as SHC's first elected Chief of Staff from 2008-2011.
As Chief of Staff, Dr. Bohman established Stanford’s wellness committee and subsequently shepherded the founding of its WellMD Center in 2015, serving as the Center’s interim Director until 2017. The Center’s aim is to advance faculty, trainee and care team wellbeing across Stanford Medicine while also serving as an international leader of scholarship in occupational wellbeing. Bryan also led the establishment in 2014 of the CELT program, which continues to serve as a driver of clinical quality improvement across Stanford Medicine.
Dr. Bohman’s primary areas of interest include occupational wellbeing, process improvement, and the reciprocal influences between quality improvement, healthcare system performance, and the occupational wellbeing of healthcare personnel. -
Paul Bollyky
Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsBacteriophages, viruses that infect bacteria, are abundant in the human body. However, their contributions to human health and disease are largely unknown. The Bollyky Lab
studies interactions between phages and both their human and bacterial hosts with the goal of developing innovative strategies to improve human health. -
Hector Fabio Bonilla
Clinical Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Vandana Boparai, MD
Clinical Assistant Professor (Affiliated), Medicine - Primary Care and Population Health
BioDr. Vandana Boparai is board certified in Internal Medicine. Her interest in clinical research is one of the reasons she joined medicine. She has been involved in many gastrointestinal research projects in affiliation with Stanford University. Her professional interests include healthcare maintenance, preventative medicine and women’s health, hypertension, acid reflux and diabetes management.
In her free time, she loves spending time with her kids. They love to swim together, and when time allows they love to travel all over the world. Her favorite tourist destination has been the Great Barrier Reef. -
Rupan Bose, MD, MB
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioRupan Bose, MD, MB, is a Cardiologist and Clinical Assistant Professor in the Division of Cardiovascular Medicine at Stanford University. He specializes in Preventive Cardiology, with a particular focus on high-risk populations. His mission is to identify the underlying drivers of cardiovascular risk, and his clinic is focused on taking a data-driven approach to addressing each of those individual risk factors. He is also deeply involved in the intersection of medicine and technology, with a particular focus on leveraging emerging technologies and innovations to improve cardiovascular disease monitoring and outcomes.
Dr. Bose is a local Bay Area native. He completed his Medical Degree from the Keck School of Medicine of USC. He then completed his Residency in Internal Medicine at USC, followed by his Fellowship in Cardiovascular Medicine at Harbor-UCLA. With his interest in medicine and technology, he holds a Masters in Biotechnology (MB) with an emphasis on Bioinformatics from the University of Pennsylvania.
At Stanford, Dr. Bose serves in the Preventive Cardiology clinic and also the Stanford South Asian Translational Heart Initiative (SSATHI) clinic. He also serves as the Medical Director for the Inpatient Cardiology Services and the Medical Director of the Inpatient Cardiology (J7) Unit. Additionally, he serves on the Cardiology Consult service and Inpatient Cardiology service, where he supervises and teaches Fellows, Residents, and Medical Students from the Stanford University School of Medicine.
